Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-06

FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (NORTHSTAR RX LLC)

View source ↗

Summary

FDA approved a supplemental application for clotrimazole and betamethasone dipropionate topical from NorthStar RX LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole and betamethasone dipropionate (clotrimazole and betamethasone dipropionate)

Snippet

SUPPL AP for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)